Ireland ready to be global leader in high-value biopharma services
A new BioPharma Business Services (BBS) strategy will be launched on Thursday for Ireland's biopharmaceutical and chemical sector.
A new BioPharma Business Services (BBS) strategy will be launched today for Ireland's biopharmaceutical and chemical sector.
The strategy aims to position Ireland as a hub for global services by leveraging the country's position as a leading manufacturing location and diversifying and strengthening the industry ecosystem in the country.




